Pure Global

Aosei Methoxysulfonamide 25 mcg paper ingots - Taiwan Registration 71509b3f5fb9622ac4e7e43f7f02a881

Access comprehensive regulatory information for Aosei Methoxysulfonamide 25 mcg paper ingots in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 71509b3f5fb9622ac4e7e43f7f02a881 and manufactured by OXOID LIMITED. The authorized representative in Taiwan is Qixin Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
71509b3f5fb9622ac4e7e43f7f02a881
Registration Details
Taiwan FDA Registration: 71509b3f5fb9622ac4e7e43f7f02a881
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Aosei Methoxysulfonamide 25 mcg paper ingots
TW: ๅ‚ฒไธ– ็”ฒๆฐง็ฃบ่ƒบ25ๅพฎๅ…‹็ด™้Œ 
Risk Class 2
Cancelled

Registration Details

71509b3f5fb9622ac4e7e43f7f02a881

DHA00601615104

Company Information

United Kingdom

Product Details

It is used as an antibiotic susceptibility test for methosulfonamide.

C Immunology and microbiology

C.1620 ๆŠ—่Œๆ„Ÿๅ—ๆ€ง่ฉฆ้ฉ—็›ค

import

Dates and Status

Mar 15, 2006

Mar 15, 2011

Nov 08, 2012

Cancellation Information

Logged out

่จฑๅฏ่ญ‰ๅทฒ้€พๆœ‰ๆ•ˆๆœŸ